Amicus Therapeutics Inc
FOLD
Market Cap$2.91B
Close$
$12.62
29.7% upside
Current Fair Value
29.7% upsideUndervalued by 29.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.91 Billion |
|---|---|
| Enterprise Value | $3.12 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.51 |
| Beta | 0.67 |
| Outstanding Shares | 304,690,596 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -28.32 |
|---|---|
| PEG | 7.35 |
| Price to Sales | 9.73 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.32 |
| Enterprise Value to EBIT | -47.1 |
| Enterprise Value to Net Income | -86 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 2.49 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amicus Therapeutics Inc
CEO: John Crowley